Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-446-3 | CAS number: 95-74-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
An Ames test in Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 was negative with and without metabolic activation (NTP 1983). In another poorly documented Ames Assay with and without metabolic activation tested in 3 Salmonella Typhimurium strains ( TA1535, TA100, TA98) a weak evidence of mutagenicity was found only in TA 100 with exogenous metabolic activation from hamster-induced liver S9 (NTP 1989).
In an additional Ames test 3-Chloro-p-toluidine hydrochloride (CPT-HCl) was tested in Salmonella typhimurium strains TA1535, TA1537, TA1538, TA98, and TA100. The test and control articles were evaluated in triplicate cultures in all five tester strains; evaluations were performed in the presence and absence of an exogenous metabolic activation system (S9).
Data obtained with this Ames/Salmonella plate incorporation assay indicate that CPT-HCl was not associated with mutagenic effects under the conditions/criteria of the test protocols.
In a chromosomal aberration assay the test substance was tested with and without metabolical activation in Chinese Hamster Ovary Cells. The test concentrations used were: without metabolical activation: 16, 50, 160 µg/ml and with metabolical activation: 50, 160, 500 µg/ml. Without metabolic activation, the rate of chromosomal aberrations was slightly increased; with metabolic activation, no significant increase in the rate of chromosomal aberrations was observed. Due to the test results, the test substance was found to be equivocal for chromosomal aberrations.
In an additional Chromosome aberration assay 3-Chloro-p-toluidine hydrochloride (CPT-HCl) was tested in CHO cells. CPT-HCI was evaluated in duplicate cultures at concentrations of 25, 125, 250, and 350 µg/ml with and without S9. There were no statistically significant or concentration-dependent increases in aberrations/cell or percent aberrant metaphases observed in any of the cultures treated with CPT-HCI in the absence of S9. In contrast, statistically significant, concentration-dependent increases in aberrations/cell and the percent aberrant metaphases were observed in the two highest concentration cultures (250 and 350 µg/ml) treated in the presence of S9.
3-Chloro-p-toluidine hydrochloride (CPT-HCl) was tested in the Chinese hamster ovary/hypoxanthineguanine phosphoribosyltransferase (CHO/HPRT) forward gene mutation assay in CHO cells. Based upon the results of a preliminary cytotoxicity screen, CPT-HCl was evaluated in duplicate cultures in the mutation assay at concentrations of 5, 10, 50, 100, 150, 200, 250, 300, 350, and 400 µg/ml with S9, and 5, 10, 50, 100, 500, 600, 700, 800, 900, and 1000 µg/ml without S9.
There were no statistically significant or concentration-dependent increases in the average mutant frequencies among the cultures treated with CPT-HCl.
In a sister chromatid exchange assay the test substance was tested with and without metabolical activation in Chinese Hamster Ovary Cells. The test concentrations used were: without metabolical activation: 5, 16, 50 µg/ml; with metabolical activation: 50, 160, 500 µg/ml. The rate of sister chromatid exchanges was slightly increased only in the presence of metabolic activation. Therefore the test substance was found to be weak positive in the sister chromatid exchange assay.
In the in vitro rat primary hepatocyte UDS assay from 1.25 µg/ml to 60 µg/ml in five trials a marginal increase in nuclear labeling in all experiments was found and was considered weakly positive.
The UMU test and the microscreen prophage-induction assay were negative.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No OECD guideline or GLP defined. Only 4 Salmonella typhimurium strains tested.
- Principles of method if other than guideline:
- Bacterial reverse mutation assay (Ames test).
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Ames test
- Species / strain / cell type:
- other: Salmonella typhimurium TA 98, TA 100, TA 1535, TA 1537
- Metabolic activation:
- with and without
- Test concentrations with justification for top dose:
- 0.0, 10.0, 33.0, 100.0, 333.0, 1000.0, 3333.0 µg/plate.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- not specified
- Positive control substance:
- not specified
- Details on test system and experimental conditions:
- Ames test.
- Species / strain:
- other: Salmonella typhimurium TA 98, TA 100, TA 1535, TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Executive summary:
In an Ames test the test substance was tested in following strains of Salmonella typhimurium with and without metabolic activation TA 98, TA 100, TA 1535, TA 1537. The test concentrations used were: 0.0, 10.0, 33.0, 100.0, 333.0, 1000.0, 3333.0 µg/plate.
The test substance did not prove to be mutagenic in the Ames test for the strains of Salmonella typhimurium tested.
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No OECD guideline or GLP defined, insufficient data documentation, no substance concentrations given.
- Principles of method if other than guideline:
- Bacterial reverse mutation assay (Ames test).
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Ames Assay
- Species / strain / cell type:
- other: Salmonella typhimurium TA 98, TA 100, TA 1535
- Metabolic activation:
- with and without
- Test concentrations with justification for top dose:
- No substance concentrations given.
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Dimethylsulfoxide
- True negative controls:
- not specified
- Positive controls:
- not specified
- Positive control substance:
- not specified
- Details on test system and experimental conditions:
- Ames test
- Metabolic activation:
- with and without
- Genotoxicity:
- other: weak positive
- Executive summary:
In a poorly documented Ames Assay with and without metabolic activation tested in 3 Salmonella Typhimurium strains ( TA1535, TA100, TA98) a weak evidence of mutagenicity was found.
Referenceopen allclose all
Results:
TA 100 | TA1535 | TA 1537 | TA 98 | |||||||||
Dose | NA | RLI | KLI | NA | RLI | KLI | NA | RLI | KLI | NA | RLI | KLI |
0.0 | 109 +/- 6.2 | 155 +/- 3.4 | 158 +/- 12.6 | 24 +/- 0.9 | 28 +/- 6.3 | 24 +/- 3.4 | 7 +/- 1.2 | 9 +/- 1.5 | 16 +/-1.2 | 23 +/-5.7 | 22 +/-0.9 | 37 +/-2.4 |
10.0 | 27 +/- 2.7 | 32 +/- 0.7 | 32 +/- 2.7 | 29 +/-2.9 | 24 +/-1.5 | 35 +/-6.1 | ||||||
33.0 | 112 +/- 7.6 | 150 +/- 10.2 | 172 +/- 9.1 | 16 +/- 4.1 | 39 +/- 2.3 | 35 +/- 4.0 | 8 +/- 0.9 | 12 +/- 0.9 | 21 +/- 4.7 | 26 +/-1.5 | 21 +/-1.5 | 36 +/-2.2 |
100.0 | 122 +/- 10.0 | 140 +/- 2.6 | 172 +/- 14.2 | 25 +/- 3.5 | 35 +/- 1.3 | 28 +/- 3.0 | 5 +/- 0.9 | 10 +/- 1.2 | 12 +/- 1.8 | 23 +/-2.6 | 25 +/-2.5 | 31 +/-2.5 |
333.0 | 111 +/- 10.0 | 162 +/- 2.2 | 150 +/- 3.0 | 18 +/- 2.6 | 32 +/- 1.5 | 21 +/- 11.6 | 5 +/- 2.0 | 8 +/- 0.6 | 14 +/-2.3 | 18 +/- 4.5 | 20 +/-0.9 | 35 +/-3.5 |
1000.0 | 81 +/- 9.6 | 145 +/- 7.0 | 154 +/- 17.6 | 9 +/- 5.2 | 15 +/- 7.7 | 23 +/- 6.4 | 3 +/- 1.2 | 5 +/- 2.6 | 8 +/- 1.2 | 30 +/-5.5 | 8 +/-3.8 | 21 +/-8.3 |
3333.0 POS | 120 +/- 5.5 | 152 +/- 2.0 | 152 +/- 1.5 | 0 +/- 0.0 | 5 +/- 2.3 | 7 +/-2.0 | ||||||
POS | 1268 +/- 11.3 | 2100 +/- 17.9 | 2458 +/- 49.7 | 1482 +/- 7.3 | 186 +/- 23.5 | 229 +/- 20.2 | 249 +/- 32.5 | 170 +/-12.1 | 100 +/-5.9 | 304 +/-46.9 | 1371 +/-78.6 | 2079 +/-50.4 |
Strain: TA1535 | ||
S9 Activation | S9 Species | Concentration |
5% HLI | Hamster | 5% |
30% HLI | Hamster | 30% |
10%HLI | Hamster | 10% |
Strain: TA100 | ||
S9 Activation | S9 Species | Concentration |
NA | NA | NA |
5% HLI | Hamster | 5% |
30% RLI | Rat | 30% |
30% HLI | Hamster | 30% |
10% HLI | Hamster | 10% |
Strain: TA98 | ||
S9 Activation | S9 Species | Concentration |
NA | NA | NA |
30% RLI | Rat | 30% |
30% HLI | Hamster | 30% |
Concentration denotes the percentage of S9 in the S9 mixture (metabolic activation enzymes and cofactors from Aroclor 1254 -induced male Sprague-Dawley rat or Syrian hamster liver) that was added to cultures. Standard NTP Protocol.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Genetic toxicity in vivo
Description of key information
No valid study is available.
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
An Ames test in Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 was negative with and without metabolic activation (NTP 1983). In another poorly documented Ames Assay in 3 Salmonella Typhimurium strains ( TA1535, TA100, TA98) a weak evidence of mutagenicity was found only in TA 100 with exogenous metabolic activation from hamster-induced liver S9 (NTP 1989).
A further Ames test in in Salmonella typhimurium strains TA1535, TA153 7, TA1538, TA98, and TA100 was negative.
In a chromosomal aberration assay without metabolic activation, the rate of chromosomal aberrations was slightly increased; with metabolic activation, no significant increase in the rate of chromosomal aberrations was observed. Due to the test results, the test substance was found to be equivocal for chromosomal aberrations. A further chromosomal aberration test there were no statistically significant or concentration-dependent increases in aberrations/cell or percent aberrant metaphases observed in any of the cultures treated with CPT-HCI in the absence of S9. In contrast, statistically significant, concentration-dependent increases in aberrations/cell and the percent aberrant metaphases were observed in the two highest concentration cultures (250 and 350 µg/ml) treated in the presence of S9.
The results of the chromosome aberration tests were contradictory.
In a sister chromatid exchange assay the rate of sister chromatid exchanges was slightly increased only in the presence of metabolic activation. Therefore the test substance was found to be weak positive in the sister chromatid exchange assay.
In the in vitro rat primary hepatocyte UDS assay from 1.25 µg/ml to 60 µg/ml in five trials a marginal increase in nuclear labeling in all experiments was found and was considered weakly positive.
The other genotoxicity tests revealed an inconclusive or weak positive result.
Based on the results of the available genotoxicity tests the overall result is inconclusive and a classification according to CLP classification criteria (Regulation (EC) No 1272/2008) is not feasible.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
